HK1118744A1 - Lipoxin analogs as novel inhibitors of restenosis - Google Patents

Lipoxin analogs as novel inhibitors of restenosis

Info

Publication number
HK1118744A1
HK1118744A1 HK08112581.2A HK08112581A HK1118744A1 HK 1118744 A1 HK1118744 A1 HK 1118744A1 HK 08112581 A HK08112581 A HK 08112581A HK 1118744 A1 HK1118744 A1 HK 1118744A1
Authority
HK
Hong Kong
Prior art keywords
restenosis
lxa
novel inhibitors
lipoxin analogs
epi
Prior art date
Application number
HK08112581.2A
Other languages
English (en)
Inventor
Charles N Serhan
Iolanda M Fierro
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Publication of HK1118744A1 publication Critical patent/HK1118744A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK08112581.2A 2001-03-02 2008-11-18 Lipoxin analogs as novel inhibitors of restenosis HK1118744A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27293101P 2001-03-02 2001-03-02

Publications (1)

Publication Number Publication Date
HK1118744A1 true HK1118744A1 (en) 2009-02-20

Family

ID=42221185

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08112581.2A HK1118744A1 (en) 2001-03-02 2008-11-18 Lipoxin analogs as novel inhibitors of restenosis

Country Status (5)

Country Link
EP (1) EP1949937B1 (de)
AT (1) ATE468157T1 (de)
DE (1) DE60236467D1 (de)
ES (1) ES2344814T3 (de)
HK (1) HK1118744A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048897A (en) * 1993-06-15 2000-04-11 Brigham And Women's Hospital Lipoxin compounds and their use in treating cell proliferative disorders
WO2000009503A1 (en) 1998-08-13 2000-02-24 Merck & Co., Inc. Integrin receptor antagonists
AU3846801A (en) 2000-02-16 2001-08-27 Brigham & Womens Hospital Aspirin-triggered lipid mediators

Also Published As

Publication number Publication date
DE60236467D1 (de) 2010-07-01
EP1949937A1 (de) 2008-07-30
ATE468157T1 (de) 2010-06-15
EP1949937B1 (de) 2010-05-19
ES2344814T3 (es) 2010-09-07

Similar Documents

Publication Publication Date Title
PT1406698E (pt) Análogos de lipoxina como novos inibidores da angiogénese
SI1780197T1 (sl) 5-substituirani-2-fenilamino benzamidi kot mek-inhibitorji
GR3023177T3 (en) Substituted heterocyclic carboxylic acid amide esters, their preparation and their us as medicaments.
AP1526A (en) Sertraline salts and sustained-release dosage forms of sertraline.
MXPA03010435A (es) Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes.
HUT70836A (en) 1-h-indole-3-acetamide spla2 inhibitors, process for producing them and pharmaceutical compositions comprising same compounds
GR3031917T3 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
WO2008021625A3 (en) Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
EP0346927A3 (de) N-substituierte 3-Piperidin-carbonsäure oder N-substituierte 3-Pyridin-carbonsäure und ihre Derivate
HK1118744A1 (en) Lipoxin analogs as novel inhibitors of restenosis
IL172134A0 (en) Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
WO2001003688A3 (en) Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
YU15002A (sh) Upotreba alfa-lipoinske kiseline ili njenih derivata
EP1174151A4 (de) Vorbeugende oder therapeutische medikamente für verschiedene eosinophilie-verwandte krankheiten enthaltend chymase hemmstoffe als aktiven bestandteil
ES2147499A1 (es) Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos.
SI1546083T1 (sl) Nove substituirane arilheksadienojske kisline in njihovi estri ki se lahko uporabljajo za zdravljenje in preprečevanje diabetesa dislipidemije in ateroskleroze farmacevtski sestavki ki jih vsebujejo in postopek njihove priprave
AP2003002905A0 (en) Sertraline salts and sustained-release dosage forms of sertraline.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140301